Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Malignant Lymphoma

Free Subscription 19.01.2026 2 Blood 1 BMC Cancer 1 Bone Marrow Transplant 2 Br J Haematol 1 Haematologica 1 Hum Pathol 1 J Natl Cancer Inst 1 Mod Pathol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Blood

1. FLERLAGE JE, Feraco AM MD, MMSc, Zhou Y, Zheng Y MS, et al
   Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08.
   Blood. 2026 Jan 13:blood.2025029535. doi: 10.1182/blood.2025029535.
   PubMed         Abstract available
   
   
2. THOMPSON C, Trneny M, Morschhauser F, Salles G, et al
   PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.
   Blood. 2026;147:254-265.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. OJALA E, Kuitunen H, Ronka A, Pellonpera E, et al
   Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.
   BMC Cancer. 2026 Jan 17. doi: 10.1186/s12885-026-15556.
   PubMed        
   
   

   
   Bone Marrow Transplant

4. SIMON L, Vucinic V, Rejeski K, Schubert ML, et al
   Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.
   Bone Marrow Transplant. 2026 Jan 16. doi: 10.1038/s41409-025-02789.
   PubMed        
   
   

   
   Br J Haematol

5. GOWDY SC, Flerlage JE, Seelisch J, Palese M, et al
   Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL Group.
   Br J Haematol. 2026 Jan 14. doi: 10.1111/bjh.70329.
   PubMed         Abstract available
   
   
6. KIM K, Shah R, Ayers A, Ahmed S, et al
   Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphoma.
   Br J Haematol. 2026 Jan 11. doi: 10.1111/bjh.70325.
   PubMed         Abstract available
   
   

   
   Haematologica

7. SIMONSEN MR, Eyre TA, Hawkes EA, El-Galaly TC, et al
   Older patients with lymphoma: navigating a landscape of clinical controversies and barriers to innovation.
   Haematologica. 2026 Jan 15. doi: 10.3324/haematol.2025.288700.
   PubMed         Abstract available
   
   

   
   Hum Pathol

8. MIYAGI MAESHIMA A, Kaimi Y, Takahashi Y, Ochi T, et al
   Consideration of the natural history of BCL2-positive follicular lymphoma: based on tumor site, histological grade, and histological transformation rate.
   Hum Pathol. 2026 Jan 13:106048. doi: 10.1016/j.humpath.2026.106048.
   PubMed         Abstract available
   
   

   
   J Natl Cancer Inst

9. BAILEY JT, Chang CJ, Gaston SA, Jackson CL, et al
   Use of hair straighteners and chemical relaxers and incidence of non-reproductive cancers.
   J Natl Cancer Inst. 2026;118:94-101.
   PubMed         Abstract available
   
   

   
   Mod Pathol

10. KANZARIA A, Arora S, Naik A, Dhanushkodi N, et al
    Biomarkers Informed by Single-Cell and Spatial Transcriptomics - Biomarkers for Grade 3 Follicular Lymphoma.
    Mod Pathol. 2026 Jan 9:100958. doi: 10.1016/j.modpat.2026.100958.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.